Human Adaptation for Space

There are two ways to close the gap between what deep space does to a human body and what a human body will tolerate. Change the environment — shielding mass, artificial gravity, a faster trajectory, a launch date chosen against the solar cycle. Or change the human. This brief is about the second lever, and about the arithmetic that decides whether it is the right one to pull.

Established The insults are not one problem but three, and they have different shapes. Radiation is a factor-of-two problem: a crewed Mars mission is projected at roughly 1,000 to 1,200 mSv against a career limit of 600 mSv, and that limit is a derived number rather than a physical threshold. Established Bone loss is bounded, has a working countermeasure, and mostly recovers. Established The ocular syndrome has no validated countermeasure, no in-flight measurement of its presumed driver, and NASA's own risk register scores it worse for a three-year planetary mission than for anything else in low Earth orbit.

Speculative Every serious engineered-adaptation proposal in the fetched record — tardigrade Dsup, extra copies of p53, an amino-acid-synthesising kidney, torpor as radioprotection, sclerostin-pathway bone modification — targets radiation or bone. None targets the eye. Speculative That inversion is the most informative single fact in the subject: the field proposes to modify the human for the two problems mission design already has levers against, and proposes nothing at all for the one nobody understands.

Frontier The framing under test is humans can be engineered to survive deep space. The record supports something narrower and more useful. The leading genetic countermeasure has been demonstrated against the wrong kind of radiation, in the wrong cell type, with a directly contradicting result in the tissue that matters most for a multi-year transit — and it is offered against a dose gap that the choice of launch window already swings by a factor of three.

Established The transit dose has been measured, not merely modelled. The Radiation Assessment Detector rode inside the Mars Science Laboratory cruise stage and recorded an average galactic-cosmic-ray dose-equivalent rate of 1.8 mSv/day behind spacecraft structure, giving roughly 0.66 Sv for the round-trip transit phases alone at current propulsion speeds, before any time on the surface. Established That is the anchor number for the entire subject, and it is an instrument reading from inside a real vehicle on a real trajectory rather than a shielding calculation.

Established NASA's exposure standard is a risk standard, and the millisievert figure is downstream of it. The career limit is 600 mSv, adopted to cap the mean excess risk of cancer-related death (REID) at 3 per cent above baseline. Established ISS crew accumulate roughly 0.2 to 0.5 mSv/day, or about 40 to 90 mSv per six-month increment. Established A crewed Mars mission of 870 to 1,250 days is projected at 1,000 to 1,200 mSv overall — but the same source gives about 525 mSv at solar maximum against about 1,625 mSv at solar minimum, because a strong solar cycle suppresses the galactic component. Established Radiation quality and dose rate are named as the largest sources of uncertainty in the underlying risk model, which is another way of saying the 600 is soft in both directions. Established The 2021 National Academies review recommended the universal 600 mSv figure specifically to replace age- and sex-dependent limits, under which, in the review's own words, “women astronauts currently cannot fly as many days in space because they would reach the radiation limit sooner.”

Established More shielding is not monotonically better, and this is the single most counter-intuitive established fact in space radiobiology. Galactic cosmic rays are mostly high-energy protons plus HZE ions, with energy peaks reaching 1,000 MeV per nucleon and heavy nuclei to 10,000 MeV per nucleon. Established Thin shielding fragments those nuclei and produces a secondary particle shower: “thin shielding may actually make the problem worse for some of the higher energy rays, because of the increased amount of secondary radiation,” and in interplanetary space “thin aluminium shielding would give a net increase in radiation exposure.” Established The ISS hull gives a net reduction only because of the geomagnetic environment it sits inside and the mass it carries; the result does not transfer to a transit vehicle.

Established Bone loss is real, quantified, and largely recoverable — which makes it the wrong target for a genetic fix. Sibonga and colleagues, across 45 crew members and 56 pre/post measurement sets, found averaged bone-mineral losses after long-duration flight of 2 to 9 per cent across lumbar spine, trochanter, pelvis, femoral neck and calcaneus, with an exponential recovery model predicting 50 per cent restoration at all sites within about nine months. Established The residual is not zero: Gabel and colleagues imaged the distal tibia by HR-pQCT in 17 astronauts (14 male, 3 female, mean age 46.9, missions of four to seven months, mean 170 days) and found failure load, total BMD and trabecular BMD still 0.9 to 2.1 per cent below preflight at twelve months after return, with failure load at −3.9 per cent for missions over six months against −0.4 per cent for shorter ones, and nine of seventeen astronauts not fully recovered. Established The authors describe that residual as commensurate with a decade or more of terrestrial age-related bone loss. Established ISS crew exercise at least two hours daily on two treadmills and the advanced Resistive Exercise Device, and those are the numbers with the countermeasure running.

Frontier The muscle number everyone quotes is one this brief will not print. The claim in wide circulation — that astronauts lose up to 20 per cent of muscle mass in five to eleven days without exercise — traces to a secondary source and could not be confirmed against the primary ISS single-fibre and MRI-volume literature. Frontier The primary papers that were sought report whole-muscle volume losses of order 10 to 20 per cent over roughly 180 days and with exercise countermeasures, which differs from the circulating claim by more than an order of magnitude in rate. Established What is solid, and separately sourced, is the cardiovascular deconditioning: blood volume falls by up to 22 per cent, producing orthostatic intolerance on return, and the unloaded spine extends within about a month for a height gain of roughly 2.5 cm. Handwave A rate quoted without its denominator is the characteristic failure mode of this literature, and it is worth noticing that the most-repeated physiological number in the field is one that could not be run to ground.

Established The ocular syndrome is where the record is worst and the numbers most often misquoted, because three different published prevalences measure three different things. Clinically significant optic disc oedema at Frisen grade 1 to 3 after long-duration flight runs at about 15 per cent; the incidence of spaceflight-associated neuro-ocular syndrome (SANS) among long-duration astronauts is reported at about 70 per cent; and 81 per cent of NASA astronauts show at least one ocular SANS feature. Established The founding cohort found optic disc oedema in five of seven, globe flattening in five of seven, cotton-wool spots in three of seven, and hyperopic shifts of +0.50 to +1.75 dioptres; more than 20 per cent of long-duration astronauts show choroidal or retinal folds, and in-flight optical coherence tomography has found choroidal thickening in every astronaut tested. Established Persistence is the alarming part: optic disc oedema documented to 180 days post-mission, asymmetric optic disc changes to 630 days, and globe flattening to seven years.

Established And the mechanism is unresolved because the decisive measurement has never been taken. Post-flight lumbar puncture opening pressures of 28 to 28.5 cm H2O are only moderately elevated and, in the reviewers' words, do not seem to be in the markedly elevated range of terrestrial idiopathic intracranial hypertension. Frontier The live hypotheses are global intracranial pressure elevation, cerebrospinal fluid compartmentalisation within the optic nerve sheath acting as a possible one-way valve, and cephalad fluid shift with venous congestion and choroidal expansion. Established The 2026 expert consensus states plainly that direct intracranial-pressure measurement during spaceflight has never been performed. Established On countermeasures the same consensus is thin: anticipation glasses correct the hyperopic shift; lower body negative pressure at 20 to 25 mmHg is safe and shows limited choroidal engorgement when used eight hours nightly; and short-arm centrifuge artificial gravity has so far not shown improvements in intraocular pressure. Established NASA's Human Research Roadmap rates the SANS/intracranial-hypertension risk 3 × 2 for six-month and one-year LEO missions but 3 × 4 for one-year deep space and for three-year planetary missions, on both the mission-operations and long-term-health axes.

Established The NASA Twins Study is the field's most cited human dataset and it is an n of one against a control of one. Across Scott Kelly's 340-day mission and ten coordinated investigations: telomere length changed in flight with increased numbers of short telomeres persisting at six months after return; 91.3 per cent of gene-expression changes reverted, a small subset persisting past six months; body mass fell 7 per cent and he consumed about 30 per cent fewer calories than anticipated; cognitive performance was largely unchanged in flight but showed a more pronounced decrease in speed and accuracy after landing that persisted for six months; carotid artery distension and intima-media thickness increased; and ocular structure altered, including subfoveal choroidal and peripapillary total retinal thickness. Established NASA published no radiation dose figure in its own summary of the study. Frontier What the design can support is a catalogue of things that change and a demonstration that most of them revert. Handwave What it cannot support — and what it is routinely used to support — is any statement about how a population of humans responds, because a single unblinded subject with a single genetically matched control has no error bar at all.

Established The replication that matters came from a commercial three-day flight, not from a year on station. The Space Omics and Medical Atlas reported on Inspiration4: four crew aged 29, 38, 42 and 51, three days at 585 km. Telomeres lengthened 17 to 22 per cent during flight (P = 0.0048) — the Twins Study's most striking single finding, reproduced in four unrelated people after seventy-two hours. Established More than 95 per cent of markers returned to baseline in the months after the mission. Established Immune and inflammatory signalling moved: IL-6 (P = 0.014), IL-10 (P = 0.021) and CCL2 (P = 0.040) rose, BDNF fell (P = 0.00011) and IL-19 rose (P = 0.00015) post-flight. Established Genome sequence and clonal haematopoiesis were stable while immune, cell-free DNA, mitochondrial and telomere measures were not, which is the correct shape of the finding: spaceflight is an acute physiological perturbation with fast reversion, not a mutagenic event you can see in a genome after days.

Established The founding engineered-adaptation result is real, specific, and narrower than its reputation. Hashimoto and colleagues sequenced Ramazzottius varieornatus (55.8 Mbp, 199 scaffolds, N50 4.74 Mbp) and expressed its damage-suppressor protein Dsup — a DNA-associating protein with no sequence similarity to any known protein or motif — in human HEK293 cells. After X-irradiation: alkaline comet tail DNA 16 per cent against 33 per cent in untransfected cells at 10 Gy; neutral comet assay, which reads double-strand breaks, reduced about 40 per cent; gamma-H2AX foci reduced about 40 per cent at 1 Gy; and sustained proliferation after 4 Gy where controls died. Established That is a clean, quantified, single-gene protective effect in cultured human cells. Frontier It is also the entire evidential foundation of every proposal to radiation-harden an astronaut.

Frontier Dsup has moved from transgene to deliverable drug, and the delivery result is more encouraging than the biology behind it. Kirtane and colleagues encoded Dsup in mRNA, packaged it in ionisable lipid nanoparticles with biodegradable cationic polymers, and delivered it to oral and rectal epithelium in mice with orthotopic oral cancer, reducing radiation-induced DNA damage with local and transient expression. Frontier The motivation is radiotherapy sparing, not spaceflight, and that matters: a drug you take before a fractionated beam is a different object from a protein you express constitutively for three years.

Frontier And the single most important negative result in the subject is that Dsup expressed in cultured neurons does the opposite of what it does in HEK293 cells. It has been reported neurotoxic and to promote neurodegeneration by increasing DNA damage through the formation of double-strand breaks. Frontier That report reaches this brief through a secondary summary of a 2023 Developmental Biology paper; the primary text could not be retrieved, and the claim is therefore unreplicated and second-hand. Speculative But if it holds, it is decisive against constitutive Dsup expression in a crew member, because the central nervous system is precisely the tissue whose radiation risk drives the multi-year mission case.

Frontier Synthetic torpor is the systemic alternative: instead of hardening DNA, produce less damage per unit dose. A consortium led from GSI Helmholtzzentrum induced synthetic torpor in rats — the first demonstration of hibernation-like radioresistance in a non-hibernating species — and showed protection against accelerated carbon ions, with hypoxia and hypothermia identified as the protective factors. Frontier The number that anchors the whole idea is older and modest: naturally hibernating ground squirrels show a dose-reduction factor of 1.4 against gamma irradiation relative to active animals. Frontier A NASA-funded model of rotating 14-day torpor cycles for a four-person crew projected a 25 per cent reduction in launch costs, which is the honest reason to be interested in torpor. Speculative A DRF of 1.4 against a factor-of-two overshoot does not close the gap on its own, and human torpor induction is expected to be tested first in critical care rather than aerospace — see Human Hibernation for how far that is from a human.

Frontier Radiotrophic fungi as living shielding is the proposal whose own best test went against it. The original claim was that ionising radiation increased melanin-supported metabolism, with Cryptococcus neoformans growing three times faster than normal; a patent followed in 2014 and NASA flew an ISS experiment on radiotrophic fungi as a radiation barrier in 2018 to 2019, with no results in the fetched record. Frontier The better-controlled recent test exposed melanised Cladosporium cladosporioides and non-melanised Paecilomyces variotii to about 50 rad of caesium-137 gamma over seven days and to energy-matched 300 to 350 nm ultraviolet, and found that exposure changed pigmentation but not growth rate — ultraviolet raised pigmentation and gamma lowered it. Speculative Melanin genuinely attenuates radiation as a passive material. Attenuation is not metabolism, and the hypothesis is currently unsupported by the experiment designed to test it.

Speculative The named gene shortlist exists, is short, and is entirely somatic. The only fetched inventory names p53 (elephants carry about twenty copies and rarely develop cancer), Dsup, a Consortium for Space Genetics shortlist of “a few dozen genes” co-founded by George Church spanning reduced sleep requirement, bone density, high-altitude adaptation, larger muscles, decreased pain sensitivity, disease resistance and mental-health markers, and Harris Wang's proposal to modify the kidney to synthesise the nine essential amino acids, decoupling crew nutrition from resupply. Speculative The stated obstacles are off-target effects, pleiotropy — individual genes rarely function in isolation — an eight-to-ten-year typical path from target to FDA approval, and unknown long-term consequences. Speculative On p53 copy number the specific unknown is not addressed anywhere in the fetched record: whether elevated dosage in a human produces the elephant phenotype or the accelerated-ageing phenotype seen in some p53-hyperactive mouse models.

Speculative The cheapest untested idea in the subject is selection rather than modification. Nothing rules out selecting crew on existing human variation — DNA-repair capacity, ex vivo radiosensitivity assays, EPAS1-type hypoxia tolerance, bone-density genotype. Speculative What would have to be true is that validated human radiosensitivity biomarkers exist with enough between-person variance to matter operationally. Handwave No fetched source addresses this at all, which is remarkable: it requires no editing, no new regulatory category, and a cohort NASA already has.

Frontier The infrastructure question has quietly been answered better than the biology question. The Space Omics and Medical Atlas is built by more than 100 institutions across 25 countries and includes an international astronaut biobank — a standing multi-omic apparatus waiting for subjects, at a moment when commercial flight is producing them faster than agencies are.

Established The workback plan to a durably radiation-hardened human has eight links, and the binding ones are not the ones the field works on. In order: (1) show Dsup-class protection works against HZE ions and not only X-rays and hydroxyl radicals; (2) resolve the neuron contradiction; (3) show in vivo protection in a whole animal at mission-relevant fractionation; (4) establish the damage-marker-to-cancer-risk transfer function; (5) achieve durable, tissue-general expression; (6) show the whole approach beats the alternatives; (7) build a regulatory pathway for a healthy-astronaut somatic intervention; (8) build the occupational and ethical framework for an irreversible modification made as a condition of employment.

Speculative Link 4 is the spine, and it is the one nobody tests. Every radioprotection claim in this subject is measured as a reduction in a damage marker — comet tail moment, gamma-H2AX foci, chromosome aberrations — and then reported, implicitly, as a reduction in risk. Handwave The mapping from “40 per cent fewer double-strand breaks at 1 Gy of X-rays in HEK293” to “40 per cent less radiogenic cancer over a 900-day mission at 1.8 mSv/day of mixed-field GCR” is assumed everywhere and demonstrated nowhere. Speculative It is not obviously monotonic: repair-pathway interventions can convert breaks into misrepairs, and a marker that counts lesions does not distinguish a lesion that was fixed correctly from one that was not.

Frontier Link 2 is binding for a different reason: a single unreplicated result can eliminate the leading candidate. If constitutive Dsup is neurotoxic, the transgene route closes and only the transient mRNA-LNP route survives — which then inherits the problem that the only in vivo demonstration is topical epithelium, and neither the central nervous system, the marrow nor the gonads is reachable by that route today. Established Link 5 is an industrial capability constraint, not a scientific one, and it is shared with the whole gene-therapy field.

Speculative Link 6 is the cheapest step on the list and would probably kill the programme. A published head-to-head trade study — genetic hardening against faster transit, against optimised shielding mass placement, against solar-maximum launch timing at 525 against 1,625 mSv, against torpor at DRF 1.4 — requires no laboratory and no subjects. Handwave That it has not been published is the strongest available evidence that the proposals are motivated by what is newly possible rather than by what is binding. Speculative Links 7 and 8 are then not really bottlenecks at all but consequences: no regulator writes a pathway for an intervention whose comparative case has never been made.

Established This brief waits on results other fields produce, and on two facilities. Heavy-ion beamline time is the first: an X-ray result says almost nothing about an HZE track, because a single iron nucleus deposits its energy along a dense one-dimensional core with a delta-ray penumbra rather than as sparse isolated ionisations. Established Only a handful of facilities in the world can simulate a mixed GCR field at all, which makes beamline supply an actual rate limit on link 1 and link 3 of the workback plan.

Frontier The second dependency is radiation epidemiology that nobody in aerospace controls. The 3 per cent REID standard rests on transfer from acute high-dose-rate human cohorts to chronic low-dose-rate mixed-field exposure, and radiation quality and dose rate are named by NASA as the largest uncertainties in the model. Speculative If the risk model moves, the 600 mSv moves with it, and a mission that was over the limit can become compliant without anyone touching a genome.

Frontier Third, human torpor. Torpor as radioprotection is downstream of torpor as a physiological capability, which does not exist in humans; that dependency is typed on this map to Human Hibernation. Established Fourth, an in-flight intracranial-pressure instrument that is safe, non-invasive and validated — no such measurement has ever been made, and without it SANS has no mechanism and therefore no target. Frontier Fifth, delivery beyond the liver, which is the binding constraint for somatic editing generally and is discussed under Genetic Engineering. Speculative Sixth, and least discussed, a validated human radiosensitivity assay — the input any selection-based approach would need, and the only item on this list that could be produced from a cohort the agencies already have.

Frontier Seventh, and outside biology entirely: propulsion. Established Transit dose is a measured rate multiplied by a duration, so at the MSL/RAD figure of 1.8 mSv/day every month removed from the trajectory removes roughly 54 mSv of transit exposure. Speculative Nothing on the genetic side of this brief offers a comparable return per unit of programme risk, and the dependency runs strictly one way: a faster ship makes the biological intervention optional, while a hardened crew does not make the ship faster.

Speculative Six experiments, in the order that would actually resolve the question.

Speculative 1. Dsup at a heavy-ion beamline. Comet and gamma-H2AX assays in Dsup-expressing human cells across iron-56 and carbon tracks at NSRL, GSI or HIMAC, against the published X-ray baseline. Frontier This is a small, fundable experiment whose negative result would end the leading proposal, and the fetched record contains no sign it has been done.

Frontier 2. Replicate the neuron result. Dsup in human iPSC-derived neurons and cortical organoids, with double-strand-break and survival endpoints, powered to distinguish neurotoxicity from a cell-line artefact. Until this is settled, constitutive expression cannot be evaluated at all.

Speculative 3. Whole animal, chronic, mixed field, cancer endpoints. Dsup-expressing or Dsup-mRNA-dosed mice under chronic low-dose-rate GCR simulation, scored on tumour incidence rather than on damage markers. Handwave This is the experiment that would establish link 4 for one intervention, and it is expensive, slow and unglamorous, which is why it is not done.

Speculative 4. The transfer function itself. A dose-response study relating a measured percentage reduction in DSB markers to a measured percentage reduction in radiogenic cancer incidence, in any mammal, for any intervention. Handwave Establishing that this mapping is even approximately linear would be worth more to the field than any individual countermeasure.

Speculative 5. In-flight intracranial pressure. A validated non-invasive ICP measurement on orbit, repeated across a mission, to discriminate global elevation from optic-nerve-sheath compartmentalisation. Speculative Without it, the highest-rated Mars health risk has no mechanism, and any proposal to engineer cerebrospinal fluid dynamics is aiming at nothing.

Speculative 6. The trade study. Publish the comparison: dose against trajectory duration, against shielding mass and geometry, against launch phase in the solar cycle, against torpor at DRF 1.4, against a hypothetical 40 per cent biological protection factor. Frontier It is analysis rather than experiment, it is cheap, and it is the missing document.

Speculative And one measurement that is not an experiment at all. Radiosensitivity variance across a crew-sized human cohort — ex vivo lymphocyte assays, DNA-repair capacity, chromosome-aberration yield per unit dose — would establish whether selection has any usable range to work with. Handwave If between-person variance turns out to be small, the case for selection collapses and the case for modification strengthens; if it is large, the cheapest intervention in the subject is already available and requires no new regulatory category at all. Speculative Either result is decision-relevant, which is the property none of the marker-reduction studies has.

Established The template for a real, permanent, dose-titrated human somatic edit already exists, and it is a liver drug. VERVE-102 — an adenine base editor plus guide RNA in a GalNAc-lipid nanoparticle targeting PCSK9 — produced, in a phase 1b with fourteen patients across three cohorts, mean LDL-C reductions of 21, 41 and 53 per cent at 0.3, 0.45 and 0.6 mg/kg, with mean PCSK9 protein reductions of 46, 53 and 60 per cent and a maximum individual LDL-C reduction of 69 per cent. Frontier A single dose that permanently moves a continuous physiological variable is exactly the shape an astronaut modification would take.

Frontier And the risk side of that template is on the record too. The largest in vivo CRISPR programme, Intellia's nex-z for transthyretin amyloidosis, produced grade 4 hepatotoxicity, FDA clinical holds and a patient death against a denominator of several hundred dosed. Frontier Bespoke speed is real — a custom base editor for a single infant with CPS1 deficiency went from sequence to first dose in about six months against an estimated eighteen — which is the strongest argument that crew-specific intervention is technically approachable. Established What has not changed is that on-target editing itself produces large deletions extending over many kilobases and complex rearrangements that standard genotyping misses, because it looks only near the cut site.

Speculative A multi-gene astronaut payload has no delivery vehicle at all. A Consortium-style shortlist of a few dozen genes is not a base-editing problem; it is a chromosome-engineering problem. Speculative Human artificial chromosomes are the route that has been proposed for three decades and has never produced a therapy. Handwave The honest engineering statement is that the field can currently install one edit in one organ, transiently or permanently, and the proposals assume dozens across every tissue including the CNS and the germline.

Established The technologies that actually compete with engineering the human are propulsion and shielding, and both are further along. Transit dose scales with transit time, so any propulsion improvement is a dose reduction; mass placement and hydrogen-rich shielding materials attack the secondary-particle problem that thin aluminium creates; and an artificial magnetosphere is the shielding concept that would, if it worked, remove the problem rather than attenuate it.

Established Artificial gravity is the countermeasure with the broadest theoretical reach and the thinnest evidence. It should address bone, muscle and fluid shift together; the one fetched result relevant to the eye is that short-arm centrifugation has so far not improved intraocular pressure. Frontier See Artificial Gravity.

Frontier Three biological neighbours matter. Human Hibernation supplies the torpor route and its DRF. Microbiome Engineering is the adjacent lever nobody has costed: the Inspiration4 immune and inflammatory shifts are consistent with a host-microbiome perturbation, and a microbial intervention is reversible in a way a transgene is not. Speculative Genetic Engineering supplies every delivery and safety constraint this brief inherits, and Biological Enhancement supplies the framework for asking whether a proposed change has evolutionary headroom at all.

Established The delivery science is borrowed wholesale and its constraints come with it. Lipid-nanoparticle formulation, base and prime editing, and adeno-associated capsid engineering are being developed for hepatic and haematopoietic disease indications; the astronaut case inherits every one of their tissue-tropism limits without contributing anything to solving them. Speculative The same is true in the other direction for radiotherapy: the only in vivo Dsup work exists because oncologists want to spare healthy tissue during fractionated treatment, and spaceflight is a downstream beneficiary of a clinical programme it does not fund.

Frontier Two habitat-side neighbours close the loop. Space Habitats is where the shielding mass physically lives, and the polyethylene-against-aluminium trade is decided there rather than here. Speculative Terraforming is the limiting case of the opposite strategy — change the planet rather than the occupant — and the fact that it is usually treated as more exotic than germline modification of a human population is a statement about intuitions rather than about timescales.

Established There is no regulatory pathway for a somatic genetic intervention in a healthy astronaut, and nothing in the record suggests one is being built. Every approved genetic medicine is indicated for a disease in a patient. The typical path from target to approval for such an indication is eight to ten years. Speculative A radioprotective edit in a healthy 40-year-old with no disease has no approvable endpoint, no comparator, and no natural sponsor: the benefit accrues to an employer's mission profile rather than to the recipient's health.

Frontier Which turns this into occupational health law, not medicine. The nearest existing analogue is the radiation-worker framework, where dose limits are set by a regulator and the worker's remedy is exposure control, not physiological modification. Speculative A crew member offered an irreversible edit as a condition of assignment sits outside every consent structure that framework contains, and the employer is also the flight surgeon, the researcher and the regulator's counterparty.

Established The standard itself is institutionally live. The 2021 National Academies review recommended not only the universal 600 mSv limit but an independent assessment of whether 3 per cent REID remains the right threshold for deep space at all. Frontier A standards decision could change the compliance picture for a Mars mission by more than any biological intervention now proposed, and it would be made by a committee rather than a laboratory.

Established Anything heritable is closed by law nearly everywhere. Roughly seventy countries have explicit bans on heritable human genome editing for reproduction and none explicitly permits it, which is why every space-genetics proposal in the fetched record specifies somatic modification. Frontier The astronaut biobank raises a quieter institutional problem: multi-omic data on a population small enough that no anonymisation survives contact with a launch manifest.

Frontier The research apparatus, meanwhile, has already reorganised around the commercial flight operator. The Space Omics and Medical Atlas is a consortium of more than 100 institutions across 25 countries built on a three-day private mission, which means the sample supply for human space biology is passing from an agency that sets its own exposure standard to operators who do not. Speculative The institution that will decide what a spaceflight participant may be offered is therefore unlikely to be the one that wrote the 3 per cent REID standard, and no fetched source describes a body with jurisdiction over both.

Speculative The strongest objection to engineering astronauts is not metaphysical. The position stated in the fetched inventory by a philosopher working on this specifically is that the valid objection is risk of failure and negative medical consequences — not dignity, not naturalness, not species integrity. Frontier That is a claim the evidence supports: the leading candidate protein has a reported neurotoxicity result, and the delivery platform has a death on its record.

Speculative Consent is structurally compromised in the case that actually arises. An astronaut asked to accept an irreversible modification in exchange for a mission assignment is being offered the scarcest professional opportunity in the world in exchange for a permanent change to their body, evaluated by their employer. Speculative The reversibility distinction is therefore load-bearing: transient mRNA-LNP radioprotection taken before a solar particle event is an ordinary occupational drug; a constitutive transgene is not, and the two are routinely discussed as though they were the same proposal.

Handwave Germline adaptation for an off-world population is where the argument changes character rather than degree. A child born on Mars to modified parents cannot consent, cannot return, and cannot be a control. Speculative The most systematic published taxonomy of strong germline engineering names its own bottleneck — epigenomic correction — and is written by an advocate; the honest reading is that the technical route is more clearly specified than its justification. Speculative The distributional question is sharper still: a modification that makes a person fit for Mars and unfit for Earth converts a settlement into a place people cannot leave.

Speculative And there is an evidential ethics problem specific to this subject. The field's headline human dataset is one man against his twin, and its headline protective result is one protein in one immortalised cell line against one kind of radiation. Handwave Proposing an irreversible intervention on that base is not a disagreement about values; it is a claim about evidence that the evidence does not support, and it is the version of the objection that survives even for someone with no principled objection to enhancement.

Speculative Is a Mars-native human a coherent idea? Partially. The environment differs from Earth on at least five axes — 0.38 g, a radiation field with no magnetosphere and a thin atmosphere, a 24.6-hour light cycle, an elevated cabin CO2 regime, and total dependence on a closed life-support loop. Handwave Of the gene targets named anywhere in the fetched record, none addresses gravity, which is the axis that actually differs by a factor rather than a margin and the one that drives bone, muscle, fluid shift and probably the eye.

Established The natural benchmark is instructive about timescales. The Tibetan high-altitude EPAS1 haplotype is Denisovan-introgressed, sits at high frequency in Tibetans and near-zero in Han Chinese, and is associated with lower haemoglobin at altitude — the opposite of the naive prediction. Speculative That is what a real, fixed, single-locus human environmental adaptation looks like: acquired by introgression, selected over millennia, and counter-intuitive in its mechanism.

Speculative The tie this brief declares. For a Mars sortie, the factor-of-two dose gap is closable by trajectory, shielding and launch timing, and biological modification is a high-risk answer to a solved-in-principle question. Speculative For permanent settlement, cumulative dose has no ceiling and there is no return trip, the mission-design levers saturate, and biological adaptation becomes the only lever with unbounded headroom. Handwave Both positions follow from the same numbers; which one is right depends entirely on whether the target is a flag and footprints or a population, and that is a decision about civilisational intent rather than about biology.

Handwave The version worth taking seriously is the one nobody is proposing. If an off-world population diverges, the mechanism will almost certainly not be deliberate editing but the ordinary population genetics of a small founder group under an uncharacterised selection regime — fertility, gestation and childhood development at 0.38 g, none of which has been observed in any mammal. Speculative That is an experiment a settlement runs whether or not anyone consents to it, and it is the one place where the phrase “Mars-native human” describes something that could actually happen.

These horizons track published experiments, facility availability and regulatory shape, not mission manifests:

• 10 yr: Frontier Expect the heavy-ion test of Dsup to be done and published, because it is cheap and the beamlines exist — and expect it to be the result that decides the subject. Frontier Expect the neuron contradiction to be resolved one way or the other in iPSC models. Frontier Expect commercial-crew omics to overtake agency data entirely in volume, with cohorts in the low hundreds rather than the low tens. Speculative Expect no human germline or somatic genetic modification for spaceflight, and expect at least one solar-cycle-timed Mars mission architecture to be published that makes the genetic proposals look redundant.
• 25 yr: Speculative If a transfer function from damage markers to cancer incidence is established, the whole field becomes quantitative and most current claims become checkable; if it is not, radioprotection stays a marker-reduction business indefinitely. Speculative Transient, pre-event radioprotective drugs — mRNA-delivered, local, reversible — are the plausible first arrival, entering through radiotherapy sparing rather than aerospace. Speculative Expect an in-flight intracranial-pressure measurement to exist by then, and expect it to reorganise SANS research. Frontier Expect crew selection on radiosensitivity or DNA-repair phenotype to be attempted before crew modification is, because it needs no new regulatory category.
• 50 yr: Speculative A durable, tissue-general protective modification remains the least likely item on this list, because it requires links 1 through 5 of the workback plan to have fallen in sequence and none has fallen yet. Speculative A settled Mars population, if one exists, will be adapting by behaviour, architecture and pharmacology rather than by genome, in the same way that every terrestrial extreme-environment population does. Handwave The interesting divergence at this horizon is not genetic but developmental: the first person to grow to adulthood at 0.38 g is an experiment nobody designed and nobody can stop.
• 100 / 250+ yr: Handwave At multi-generational scale the question stops being whether humans can be engineered for Mars and becomes whether an off-world population diverges without anyone engineering anything — through founder effects, small effective population size, and selection on a fertility and development environment nobody has characterised. Handwave The alternative terminal state is equally consistent with the record: that the biological problems are all bounded, that shielding and gravity are solved by engineering the habitat rather than the occupant, and that the whole engineered-human programme is remembered as a category error made at a moment when editing became cheap.

• Depends on This brief waits on one result another brief on this map is positioned to produce. Torpor as radioprotection is downstream of torpor as a demonstrated human capability, and the dose-reduction factor of 1.4 in hibernating ground squirrels is the only quantitative radioprotection number in the subject that does not come from a cell line — so Human Hibernation is a typed dependency rather than a neighbour. Everything else this brief needs is either an instrument reading nobody has taken (in-flight intracranial pressure), a facility booking (heavy-ion and mixed-field GCR beamlines), or an epidemiological transfer function that no brief on this map produces. It is worth being precise about what the typed edge does and does not assert: it says that the torpor route to radioprotection cannot be evaluated until human torpor exists, not that human torpor would deliver radioprotection. The one number in hand, a dose-reduction factor of 1.4 in ground squirrels, is smaller than the gap it is offered against, so this dependency could be satisfied in full and still leave the radiation case unchanged.
• Enables If a durable, tissue-general radioprotective modification were demonstrated, the consequences land first on mission architecture rather than on biology: the trade space behind Mars Colonization and Multi-Planetary Civilization changes, because crew-hours in deep space stop being rationed by a cancer-risk budget. No typed enabling edge is claimed, because every one of those consequences is conditional on a result that does not exist and on a transfer function nobody has measured, and a typed edge would assert a dependency the record does not support. The asymmetry is worth stating plainly: this brief has a supplier and no customers. That is the correct shape for a subject whose central proposal has not cleared its first experiment, and it should be read as a finding rather than as an absence — nothing downstream is currently waiting on engineered human adaptation, because no mission architecture on the record assumes it.
• Adjacent Space radiation biology and heavy-ion radiobiology; ophthalmology and cerebrospinal fluid dynamics, which own the unsolved problem; comparative extremophile genomics, which supplies Dsup; lipid-nanoparticle and base-editing delivery science; occupational radiation protection law. Within this map: Artificial Gravity and Artificial Magnetospheres, which attack the same three insults by changing the environment instead of the occupant; Genetic Engineering, which supplies every delivery and safety constraint; Biological Enhancement, which supplies the question of whether a proposed change has any evolutionary headroom; Microbiome Engineering, the reversible lever nobody has costed; and Space Habitats, where the shielding mass actually lives. Two further neighbours are adjacent by contrast rather than by contribution: Terraforming, the limiting case of changing the environment instead of the occupant, and Precision Medicine, which supplies the individual-variation logic that crew selection would run on.

Established “Scott Kelly's DNA changed by 7 per cent.” It did not. What changed was gene expression, and the 7 per cent was the fraction of expression changes that had not returned to baseline about six months after landing. Established NASA's clarification is explicit that his DNA did not fundamentally change and that what was observed were changes in gene expression, which is how the body reacts to its environment. Established There is a third layer the corrections rarely reach: NASA's own final write-up gives the reverted fraction as 91.3 per cent, so the persistent fraction is 8.7 per cent, not 7. The 7 came from a superseded January 2018 preliminary release.

Frontier “Astronauts lose up to 20 per cent of muscle mass in five to eleven days.” This brief does not state that number, because it could not be confirmed against primary literature. Frontier The primary ISS single-fibre and MRI-volume papers report whole-muscle losses of order 10 to 20 per cent over roughly 180 days with exercise countermeasures, which is a different claim by more than an order of magnitude in rate. Handwave A brief that repeats it is repeating a rate without a denominator, and the fact that this is the most-quoted number in the field is a fair measure of how much of the popular account is secondary.

Established “More shielding always helps.” In interplanetary space, thin aluminium shielding would give a net increase in radiation exposure, because HZE nuclei fragment in the material and produce secondaries. Established The ISS result does not generalise: that hull sits inside the geomagnetic field and carries a great deal more mass than a transit vehicle will.

Frontier “Tardigrade genes make human cells radiation-proof.” Dsup reduced measured DNA damage by roughly 40 to 50 per cent against X-rays in one immortalised human cell line. Established It has never been tested against heavy ions, which is the radiation that actually matters in deep space and which deposits energy in a fundamentally different spatial pattern. Frontier And in neurons it has been reported to increase double-strand breaks. Speculative Three separate gaps, each of which alone would be enough to withhold the claim.

Established “Tardigrades got their toughness by stealing 17.5 per cent of their genes.” That figure was a contamination artefact in a 2015 assembly. Established A higher-quality genome of Ramazzottius varieornatus found 1.2 per cent or less putative foreign genes, and its authors explicitly contrast this with the previous claims of 17.5 per cent in other tardigrade species. Established That is roughly a fifteen-fold error that survived in secondary sources for years, and it is the origin of the “tardigrades are chimeric superorganisms” framing that motivates a good deal of the horizontal-gene-transfer enthusiasm in space biology. Frontier The formal refutation paper could not be retrieved for this brief; the corrected figure is stated here from the independent high-quality assembly instead.

Frontier “Chernobyl fungi eat radiation and could shield a habitat.” The best-controlled recent test found no growth-rate change under gamma irradiation and found that gamma decreased pigmentation in a melanised species reported to be radiotrophic, while ultraviolet increased it. Speculative The hypothesis persists because the Chernobyl observation is genuinely striking and because melanin genuinely attenuates radiation as a passive material — but passive attenuation is not radiosynthesis, and a fungal mat that shields by mass is competing with polyethylene on mass, which it will lose.

Established “SANS affects 15 per cent of astronauts” and “SANS affects 81 per cent of astronauts.” Both are published and both are correct, because they measure different things: clinically significant optic disc oedema at Frisen grade 1 to 3 in the first case, at least one ocular SANS feature in the second, with an intermediate figure of about 70 per cent for SANS incidence. Handwave A brief that quotes one without its definition has not made an error of fact but has made the syndrome sound five times more or less common than it is.

Established “Bone loss in space is permanent.” About half the loss is restored within nine months, and the twelve-month residual at the distal tibia is 0.9 to 2.1 per cent, worse for missions over six months at a failure-load deficit of 3.9 per cent. Established The honest version is the harder one: nine of seventeen astronauts had not fully recovered tibial density at twelve months, and the residual is comparable to a decade of terrestrial age-related loss. Speculative Both readings are true, and the reason this matters is prioritisation — the genetic proposals aimed at bone are aimed at the one problem of the three that already has a countermeasure and a known recovery curve.

Established “The Mars radiation dose is unsurvivable.” It is roughly double a career limit which is itself set to cap excess cancer death at 3 per cent — a risk-management threshold, not a lethal one. Established And launch timing alone swings the projected dose from about 525 mSv at solar maximum to about 1,625 mSv at solar minimum, a three-fold range from a decision made before anyone boards.

Established “NASA's radiation limit is 600 mSv.” NASA's standard is 3 per cent REID; the 600 mSv is derived from it under a particular risk model. Frontier State it the wrong way round and you lose the fact that the number will move if the model does — and a National Academies committee has already recommended reassessing whether 3 per cent is the right threshold for deep space.

Speculative “Torpor solves the radiation problem.” The only quantitative radioprotection number attached to torpor is a dose-reduction factor of 1.4 in naturally hibernating ground squirrels. Speculative Against a factor-of-two overshoot, 1.4 helps and does not close the gap; the strong case for torpor is consumables and launch mass, where a modelled 25 per cent launch-cost reduction is a serious claim, not radioprotection.

Handwave “Genetic engineering will produce a Mars-native human.” Every proposal in the fetched inventory specifies somatic modification, for the straightforward reason that roughly seventy countries ban heritable editing for reproduction and none permits it. Speculative None of the named targets addresses gravity, which is the one environmental axis that differs from Earth by a factor rather than a margin. Handwave And the deepest version of the misconception is a category error about what adaptation is: the natural benchmark, the Tibetan EPAS1 haplotype, was acquired by introgression from another hominin, selected over thousands of years, and works by lowering haemoglobin rather than raising it. Nobody predicted that mechanism in advance, and nobody would have engineered it.